HOW YOUR BODY KILLS CANCER CELLS

In this special report, we will look at how your body kills cancer that enter it, and the limited potency and effect of drugs. Cancer starts with a single cell. The differences between normal cells and cancer cells that the cancer cell seems to have lost a number of vital control systems.  Through damage or mutation, some of the genes in the cell have affected resulting in faulty processes.

A cancer's worst enemy is the human immune system. Common logic indicate that Prevention is Better than Cure. And also early detection is better than a late one. When a lump is discovered, it is already in the "late" category. The immune system does a cell-to-cell audit to check that cells are normal.

Your body has an immune system, which you can liken to your Ministry of Defence.  Of the
many immune cells - "NK cells", "B cells", "T cells", "anti-bodies", "interferon" etc.  all have a function in KEEPING YOU HEALTHY, WHEN THE CANCER HAS GAINED ENTRY INTO YOUR BODY.  Think of the times when someone in the office has the flu and others don't.  The difference is the "fire power" of your immune system, and its IDENTIFICATION SYSTEM - TO RECOGNISE AND KILL FOREIGN MATTERS IN YOUR BODY.

"WHO" MONITORS CANCERS, BACTERIA OR VIRAL INVASIONS?

At the heart of the immune response is the ability to distinguish between self and nonself. Every body cell carries distinctive molecules that distinguish it as "self." Normally the body's defenses do not attack tissues that carry a self marker; rather, immune cells coexist peaceably with other body cells in a state known as self-tolerance. When a cancer has inflitrated a cell, it changes some marker, and the ideally the immune cells then recognise this sick cell as "non-self:.

Cytotoxic T cells (sometimes called killer T cells) help rid your body of cells that have been infected by viruses as well as cells that have been transformed by cancer but have not yet adapted to evade the immune detection system. They are also responsible for the rejection of tissue and organ grafts.

Self Markers Co-exist in harmony	Non self Click to see how antibodies act against non-self

WHY THE DRUG APPROACH MAY NOT BE YOUR BEST CHOICE - WHO WOULD WANT TO DEAL WITH RESISTANT CANCER CELLS LATER?

In chemotherapy doctors are using a carpet bombing approach to destroy cancer cells: the patient is pumped full of cytotoxic drugs, that go everywhere in the body, with the hope that enough of the drugs reach the cancer cells and target their nuclear DNA to damage it or destroy the cell.

Not only do chemotherapeutic techniques have a range of often serious side effects, mainly affecting all the fast-dividing cells of the body, it also has been shown that often less than 1% of the administered drug molecules enter tumor cells and bind to the nuclear DNA. Another complication is drug resistance of cancer cells. This actually is one of the main causes of failure in the treatment of cancer. Dividing cancer cells acquire genetic changes (mutations) at a high rate, which means that the cells in a tumor that are resistant to a particular drug will survive and multiply. The result is the re-growth of a tumor that is not sensitive to the original drug.

HOW DOES THE BODY'S IMMUNE SYSTEM REACT?

Your "NK cells" - which stands for NATURAL KILLER CELLS (this is the proper name for it, as used in the scientific and medical circles and in general usage).  The NK cells targets "non-self", i.e. cells that ar not an integral part of you (or your "self").  NK cells are part of your body's innate immune response, and is in the first line of defence.

The innate immune response is characterized by the fact that it does not require prior exposure to an infectious agent.

When normal cells turn into cancer cells, some of the antigens on their surface change. These cells, like many body cells, constantly shed bits of protein from their surface into the circulatory system. Often, tumor antigens are among the shed proteins.

These shed antigens prompt action from immune defenders, including cytotoxic T cells, natural killer cells, and macrophages. According to one theory, patrolling cells of the immune system provide continuous bodywide surveillance, catching and eliminating cells that undergo malignant transformation. Tumors develop when this immune surveillance breaks down or is overwhelmed.

HOW DO NK CELLS KILL?

NK Cells contain granules filled with potent chemicals, and kill on contact. The killer binds to its target, aims its weapons, and delivers a burst of lethal chemicals.

Well, your NK cells search and destroy altered/ infected cells.  In other words if the infected cells can be stopped early enough, it is prevented from spreading in your body.  Remember it spreads alarmingly quickly - geometric progression - ie. 2 to 4, to 8,16, 32, 64 etc. in several minutes. It can grow to millions in a short time - in a matter of several hours and days.

NK Cells contain granules filled with potent chemicals, and kill on contact. The killer binds to its target, aims its weapons, and delivers a burst of lethal chemicals.

WHAT IS THE DIFFERENCE NK CELLS ACTIVITY COMPARED WITH DRUGS?

NK cell targets specifically, all "non-self" cells without prior exposure to the infectious agent. In other words the are pre-armed, fore-warned, unlike drugs.

NK CELL AND CANCER
The NK cells are the first line of defence in your body and a strong immune system and active NK cells would do a good survelliance and detection.  The host of supporting immune cells work together to fight cancer.

When normal cells turn into cancer cells, through mutation, or DNA damage, some of the antigens on their surface change. These new or altered antigens flag immune defenders, including cytotoxic T cells, natural killer cells, and macrophages.

WHAT CAN WE DO TO BOOST NK CELL ACTIVITY IN OUR BODY?
WOULD CERTAIN HEALTH SUPPLEMENTS HELP?

That is a good question.  Prominent scientists and medical researchers in the USA had conducted a 6 year study recently (late 90s) to evaluate ALL THE POPULAR NATURAL SUPPLEMENT PRODUCTS IN THE MARKET KNOWN TO BE IMMUNE BOOSTERS. The study published in peer review journal in late 1990s evaluated how much a product will (or will not) improve NK cell activity.  The study was led by a medical associate professor Darrly See (his CV here) who was with the University of California, Irivine. The studies were confirmed by Russian Scientists from the Russian Academy of Medical Sciences.

STUDIES ON IMMUNE BOOSTING HERBS, PHYTO NUTRIENTS, OTHER BIOTECH PRODUCTS

A total of 196 natural supplements & herbs  were tested and compared - such as Noni, aloe, cordyceps, ginseng, shitake mushroom, mitake mushrooms, shark cartilege, astralagus, blue cohosh, bovine colostrum, buckthorn, burdock, chaparral, dandelion, echinacea, garlic, gotu kola, milk thistle, pau d'arco, periwinkle, pycnogenol, quercetin, vitamin C, etc were tested.  In addition, chinese herbs - alone and in combinations were tested.

ONE SUBSTANCE STOOD OUT: TRANSFER FACTOR

The best performer was Transfer Factor, and Transfer Factor Plus.  The latter out-performed the next best product by 500%.  Subsequent research on cancer shows very promising results.  (See  Research materials here, and what Medical professionals say  here ).

The research shows that Transfer factor out-perform all other drug, herb, or nutritional substance in medical literature in raising NK cell activity.  In this study, the test was carried out on live Leukemia Cancer cells.

The research shows that Transfer factor out-perform all other drug, herb, or nutritional substance in medical literature in raising NK cell activity.  In this study, the test was carried out on live Leukemia Cancer cells.

WHY WOULD A PERSON'S IMMUNE SYSTEM BE WEAKENED? OR PERFORM POORLY?
There are various factors- mainly due to stress, being chronically sick (constant illness), lack of exercise, lacking nutritious food, depression/ poor mental state are some reasons.  Other reasons include high consumption of sugar and environmental pollution.  The weakened NK cell activity would benefit from Transfer factor.

FROM LABORATORY TO COMMERCIALISATION
Transfer Factor is not a new science though.  Transfer Factor was discovered in 1949 by Dr Sherwood Lawrence of New York University.  Early work was carried out with Trasfer factor from blood extracts, and with injections.  It has over 50 years of research, and an estimated US$40 million spent on research, and 3500 clinical studies and papers done.

The exciting news news is that Transfer factor is now available as a commercial product as as a health supplement - in the form of capsules, tablets, and recently (2005) in liquid form.    It is safe for even for infants and naturally safe for adults.
 

WHAT IS THE SOURCE OF TRANSFER FACTOR?

All animals produce tranfer factor, however scientists prefer to work with bovine (cow) colostrum, and with (chicken) egg yolk extract. A healthy cow already produces millions of different transfer factors, but when the cow does come into contact with a pathogen such as a virus, it produces a new transfer factor for that specific virus or pathogen.

Transfer factor is able to pass through the stomach unharmed by digestive enzymes and stomach acids. The calf is then able to easily absorb this immune memory molecule, which gives it immunity to all the same pathogens as the calf's mother. This inherited immunity will protect the baby from the same disease-causing organisms the mother was protected against.

Transfer factor crosses mammalian species lines. When a person absorbs transfer factor from a cow's colostrum and egg yolk, the person develops resistance to the pathogen to which the cow, and the chicken was exposed.

HOW IS TRANSFER FACTOR PRODUCED FOR HUMAN CONSUMPTION?

Due to practical considerations in the manufacturing and processing of transfer factor, bovine colostrum and avian egg are the preferred sources of transfer factor.

Colostrum from healthy cows is filtered and purified to provide a mixture of transfer factor molecules. Numerous rigorous techniques including further purification and isolation result in pure transfer factor. Every lot produced undergoes rigorous testing, to ensure that the appropriate and effective levels of each transfer factor are present, before it is encapsulated and bottled.

Also, people who are lactose intolerant or who have allergies need not be concerned about a reaction since all traces of milk proteins and lactose are removed during the extraction and concentration process.

USING TRANSFER FACTOR

Transfer factor will not remove or 'cure' the problem in itself; rather transfer factor works to assist and support normal immune system functioning. At the onset individuals typically begin with a high dose and then eventually taper down to a minimum maintenance dose.

BUY NOW

To buy products online click below:

LINKS to other sites

DISCLAIMER
Transfer Factor products mentioned here are not designed to prevent, diagnose, cure, or mitigate any diseases, ailments or illnesses. Transfer factors support and modulate the body's immune system.  It helps the body to protect, defend, heal itself.  If you are ill, we strongly suggest that you consult a medical doctor.
 

REFERENCES
20. AIDS and Transfer factor: myths, certainties and realities.  Viza D.  Biotherapy 1996, 9(1-3), 17-26.
21. A canine distemper virus epidemic in Serengeti lions (Pantera leo).  Roelke-Parker ME, Muson L, Packer C, Kock R, Cleaveland S, Carpenter M, et. Al.  Nature 1996, 379, 441-5.
22. Transfer factor 1993: New Frontiers.  Fudenberg HH, Pizza G.  Progress in Drug Res.  1994 42, 309-400.
98. Effect of anti-herpes specific Transfer factor.  Bryston J, Cech K, Pekarek J, Jilkova J, Biotherapy 1996, 91(1-3), 73-5.
99. Orally administered HSV-specific Transfer factor prevents genital or labial herpes relapes.  Pizza G, Viza D, De Vinci C, Palareti A, Cuzzocrea D, Fornarola V, Baricordi R.  Bioterapy 1996, 9(1-3), 67-72.
100. Efficacy of Transfer factor in treating patients with recurring ocular herpes infections. Meduri R, Campos E, Scorolli L, De Vinci C, Pizza G, Viza, D.  Biotherapy 1996, 9(1-3), 61-6.
101. Clinical study of HSV-specific Transfer factor on relapse HSVK.  Anon, Xi’an Yike Daxue Xuebao 1996, 17(3), 322-324.
102. Transfer factor prevents relapses in Herpes keratitis patients: a pilot study.  Pizza G, Meduri R, De Vinci C, Scorolli L, Viza D.  Biotherapy 1994, 8(1), 63-8.
106. Clinical, epidemilogic and virologic studies in four cluster of the chronic fatique syndrome.  Levine PH, Jacobsen S, Pocinki AG, Cheny P, Peterson D